160 related articles for article (PubMed ID: 21040551)
1. Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1.
Wang WZ; Liu HO; Wu YH; Hong Y; Yang JW; Liu YH; Wu WB; Zhou L; Sun LL; Xu JJ; Yun XJ; Gu JX
J Exp Clin Cancer Res; 2010 Nov; 29(1):140. PubMed ID: 21040551
[TBL] [Abstract][Full Text] [Related]
2. Histone acetyltransferase Hbo1 destabilizes estrogen receptor α by ubiquitination and modulates proliferation of breast cancers.
Iizuka M; Susa T; Takahashi Y; Tamamori-Adachi M; Kajitani T; Okinaga H; Fukusato T; Okazaki T
Cancer Sci; 2013 Dec; 104(12):1647-55. PubMed ID: 24125069
[TBL] [Abstract][Full Text] [Related]
3. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
4. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
Oh AS; Lorant LA; Holloway JN; Miller DL; Kern FG; El-Ashry D
Mol Endocrinol; 2001 Aug; 15(8):1344-59. PubMed ID: 11463858
[TBL] [Abstract][Full Text] [Related]
5. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
6. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.
Madak-Erdogan Z; Lupien M; Stossi F; Brown M; Katzenellenbogen BS
Mol Cell Biol; 2011 Jan; 31(1):226-36. PubMed ID: 20956553
[TBL] [Abstract][Full Text] [Related]
7. Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.
Bratton MR; Antoon JW; Duong BN; Frigo DE; Tilghman S; Collins-Burow BM; Elliott S; Tang Y; Melnik LI; Lai L; Alam J; Beckman BS; Hill SM; Rowan BG; McLachlan JA; Burow ME
J Endocrinol; 2012 Jul; 214(1):45-54. PubMed ID: 22562654
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of estrogen receptor alpha function by antisense oligodeoxyribonucleotides.
Taylor AH; Pringle JH; Bell SC; Al-Azzawi F
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):219-31. PubMed ID: 11572599
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous measurement of ERα, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry.
Bayraktar UD; Kim TK; Drews-Elger K; Benjamin C; El-Ashry D; Wieder E; Komanduri KV
Breast Cancer Res Treat; 2011 Sep; 129(2):623-8. PubMed ID: 21607585
[TBL] [Abstract][Full Text] [Related]
11. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation.
Pedroza DA; Subramani R; Tiula K; Do A; Rashiraj N; Galvez A; Chatterjee A; Bencomo A; Rivera S; Lakshmanaswamy R
Lab Invest; 2021 Jun; 101(6):733-744. PubMed ID: 33903732
[TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
14. A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.
Kim K; Madak-Erdogan Z; Ventrella R; Katzenellenbogen BS
Horm Cancer; 2013 Apr; 4(2):78-91. PubMed ID: 23250869
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.
Stope MB; Popp SL; Knabbe C; Buck MB
Breast Cancer Res Treat; 2010 Apr; 120(2):357-67. PubMed ID: 19370415
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
17. Bisphenol AF-induced endogenous transcription is mediated by ERα and ERK1/2 activation in human breast cancer cells.
Li M; Guo J; Gao W; Yu J; Han X; Zhang J; Shao B
PLoS One; 2014; 9(4):e94725. PubMed ID: 24727858
[TBL] [Abstract][Full Text] [Related]
18. A novel antiestrogenic mechanism in progesterone receptor-transfected breast cancer cells.
Zheng ZY; Bay BH; Aw SE; Lin VC
J Biol Chem; 2005 Apr; 280(17):17480-7. PubMed ID: 15728178
[TBL] [Abstract][Full Text] [Related]
19. [Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells].
Lu Y; Jiang S; Zhang J; Song H; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):925-31. PubMed ID: 25608994
[TBL] [Abstract][Full Text] [Related]
20. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.
Catalano S; Mauro L; Marsico S; Giordano C; Rizza P; Rago V; Montanaro D; Maggiolini M; Panno ML; Andó S
J Biol Chem; 2004 May; 279(19):19908-15. PubMed ID: 14985328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
